Company profile: Lumos Diagnostics
1.1 - Company Overview
Company description
- Provider of rapid point-of-care diagnostic solutions, including customized assay development, full-scale contract manufacturing for lateral flow strips and readers, proprietary digital reader platforms, companion apps, and cloud connectivity for data capture and visualization, supported by in-house clinical study design, site management, and regulatory affairs.
Products and services
- Contract Manufacturing: Lumos delivers industrial-grade, full-scale contract manufacturing for point-of-care diagnostic products, including lateral flow strips and readers, built for point-of-care use
- Customized Assay Development: Lumos architects custom-engineered assay development for point-of-care tests, tailoring designs to meet specified performance thresholds, cost targets, and regulatory requirements for intended use
- Digital Reader Platforms: Lumos engineers proprietary digital reader platforms that support point-of-care diagnostic tests, enhancing test accuracy and data management
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lumos Diagnostics
Anacor Pharmaceuticals
HQ: United States
Website
- Description: Provider of small-molecule therapeutics based on a boron chemistry platform, focused on developing topical treatments for fungal, bacterial, and inflammatory diseases, including its primary product candidate AN2690, a novel topical antifungal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anacor Pharmaceuticals company profile →
NanoView Biosciences
HQ: United States
Website
- Description: Provider of proprietary products supporting research, translation and delivery of precision medicine, built on a novel platform that uniquely identifies and characterizes exosomes. Offers high-throughput, cost-effective analysis, including Leprechaun for lentivirus and exosome biophysical characterization, contaminant detection, and concentration measurement using fluorescence and antibody-based methods.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoView Biosciences company profile →
RQx Pharmaceuticals
HQ: United States
Website
- Description: Provider of broad spectrum antibiotic development; a biopharmaceutical company founded in 2010 and based in La Jolla, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RQx Pharmaceuticals company profile →
Arpida
HQ: Switzerland
Website
- Description: Provider of biopharmaceutical discovery and development of novel products for the treatment of bacterial infections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arpida company profile →
Mymetics
HQ: Switzerland
Website
- Description: Provider of virosome-based vaccine R&D and immunotherapies, focused on next-generation preventative vaccines for infectious diseases. Pipeline includes HIV-1/AIDS, intranasal influenza, malaria, herpes simplex virus and RSV, plus candidates for Covid-19 and COP allergy immunotherapy, and research collaborations in cancer immunotherapy. Swiss-based with a research lab in the Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mymetics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lumos Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lumos Diagnostics
2.2 - Growth funds investing in similar companies to Lumos Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lumos Diagnostics
4.2 - Public trading comparable groups for Lumos Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →